• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝衰竭(ACLF)和低钠血症的联合和序贯评估及其对肝硬化患者的预后影响。

Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients.

机构信息

Gastroenterology and Hepatology Unit, Bonsucesso Federal Hospital, (Ministry of Health), Rio de Janeiro, Brazil; Estácio de Sá University, School of Medicine, Rio de Janeiro, Brazil.

Gastroenterology and Hepatology Unit, Bonsucesso Federal Hospital, (Ministry of Health), Rio de Janeiro, Brazil.

出版信息

Dig Liver Dis. 2020 Jan;52(1):91-97. doi: 10.1016/j.dld.2019.08.013. Epub 2019 Sep 19.

DOI:10.1016/j.dld.2019.08.013
PMID:31542220
Abstract

BACKGROUND

Few studies have evaluated whether combination and sequential evaluation of ACLF (acute-on-chronic liver failure) and hyponatremia aids prognosis.

AIMS

Describe clinical course and determine prognostic capability of assessing ACLF and hyponatremia at specific time-points.

METHODS

Prospective study with inclusion of 376 patients. ACLF and hyponatremia were evaluated at days 1 and 7 and classified as persistent, transient, de novo or absent. Follow-up was 90 days.

RESULTS

At inclusion, ACLF was diagnosed in 99 patients. Reversal was observed in 57 patients and was associated with lower creatinine and ACLF grade. De novo ACLF developed in 19 patients, and MELD (model of end-stage liver disease) score and lower albumin were predictive factors. Hyponatremia was present in 76 patients (persistent, transient and de novo in 27, 24 and 25 respectively). ACLF at D7 had the lowest survival compared to transient or no ACLF (21, 57 and 80%, p < 0.0001). Hyponatremia at admission was associated with low survival (35%) whereas survival was higher for de novo or absent cases (70%), p < 0.001. In multivariate analysis ACLF at D7 and hyponatremia at D1 were predictors of survival.

CONCLUSION

ACLF and hyponatremia are dynamic and evaluation of both conditions at different time-points identifies patients at higher risk of short-term mortality.

摘要

背景

很少有研究评估 ACLF(急性肝衰竭)和低钠血症的联合和序贯评估是否有助于预后。

目的

描述临床过程,并确定在特定时间点评估 ACLF 和低钠血症的预后能力。

方法

前瞻性研究,纳入 376 例患者。在第 1 天和第 7 天评估 ACLF 和低钠血症,并分类为持续、短暂、新发或无。随访 90 天。

结果

纳入时,99 例患者诊断为 ACLF。57 例患者出现逆转,与肌酐降低和 ACLF 分级相关。19 例患者新发 ACLF,MELD(终末期肝病模型)评分和白蛋白降低是预测因素。76 例患者存在低钠血症(持续、短暂和新发分别为 27、24 和 25 例)。与短暂或无 ACLF 相比,第 7 天的 ACLF 存活率最低(21%、57%和 80%,p<0.0001)。入院时的低钠血症与低生存率(35%)相关,而新发或无低钠血症的生存率更高(70%),p<0.001。多变量分析显示,第 7 天的 ACLF 和第 1 天的低钠血症是生存率的预测因素。

结论

ACLF 和低钠血症是动态的,在不同时间点评估两种情况可识别出短期死亡率更高的患者。

相似文献

1
Combination and sequential evaluation of acute-on-chronic liver failure (ACLF) and hyponatremia and prognosis in cirrhotic patients.慢性肝衰竭(ACLF)和低钠血症的联合和序贯评估及其对肝硬化患者的预后影响。
Dig Liver Dis. 2020 Jan;52(1):91-97. doi: 10.1016/j.dld.2019.08.013. Epub 2019 Sep 19.
2
Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.慢性肝衰竭联盟急性加重慢性肝衰竭和急性失代偿评分可预测巴西肝硬化患者的死亡率。
World J Gastroenterol. 2017 Jul 28;23(28):5237-5245. doi: 10.3748/wjg.v23.i28.5237.
3
Serum sodium, model for end-stage liver disease, and a recent invasive procedure are risk factors for severe acute-on-chronic liver failure and death in cirrhotic patients hospitalized with bacterial infection.血清钠、终末期肝病模型以及近期的侵入性操作是因细菌感染住院的肝硬化患者发生严重急性慢性肝衰竭和死亡的危险因素。
Eur J Gastroenterol Hepatol. 2018 Sep;30(9):1055-1059. doi: 10.1097/MEG.0000000000001184.
4
Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study.低钠血症影响慢性肝功能衰竭急性发作患者的预后:CANONIC研究分析
Crit Care. 2014 Dec 13;18(6):700. doi: 10.1186/s13054-014-0700-0.
5
Single-centre validation of the EASL-CLIF consortium definition of acute-on-chronic liver failure and CLIF-SOFA for prediction of mortality in cirrhosis.单中心验证 EASL-CLIF 联盟定义的慢加急性肝衰竭和 CLIF-SOFA 对肝硬化患者死亡率的预测价值。
Liver Int. 2015 May;35(5):1516-23. doi: 10.1111/liv.12597. Epub 2014 Jun 6.
6
Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure.肝硬化急性失代偿伴或不伴慢加急性肝衰竭患者死亡率评分的单中心验证
Scand J Gastroenterol. 2017 Dec;52(12):1385-1390. doi: 10.1080/00365521.2017.1369560. Epub 2017 Aug 29.
7
Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults.肝性和肝外因素诱发的慢加急性肝衰竭预后模型的验证。
PLoS One. 2019 Jul 10;14(7):e0219516. doi: 10.1371/journal.pone.0219516. eCollection 2019.
8
CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward.在入住病房的慢加急性肝衰竭患者中,CLIF-C ACLF评分比MELD、MELD-Na和CTP更能准确预测死亡率。
Rev Esp Enferm Dig. 2017 Jun;109(6):399-405. doi: 10.17235/reed.2017.4701/2016.
9
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.开发和验证一种预后评分系统,以预测慢加急性肝衰竭患者的死亡率。
J Hepatol. 2014 Nov;61(5):1038-47. doi: 10.1016/j.jhep.2014.06.012. Epub 2014 Jun 17.
10
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).肝硬化患者因肝性脑病住院的特征、风险因素和死亡率,伴有和不伴有慢加急性肝衰竭(ACLF)。
J Hepatol. 2014 Feb;60(2):275-81. doi: 10.1016/j.jhep.2013.10.004. Epub 2013 Oct 12.

引用本文的文献

1
Construction of a novel prognostic scoring model for HBV-ACLF liver failure based on dynamic data.基于动态数据构建新型 HBV-ACLF 肝衰竭预后评分模型。
Sci Rep. 2024 Jul 2;14(1):15198. doi: 10.1038/s41598-024-63900-4.
2
Alpha-fetoprotein and APRI as predictive markers for patients with Type C hepatitis B-related acute-on-chronic liver failure: a retrospective study.甲胎蛋白和 APRI 作为 C 型乙型肝炎相关慢加急性肝衰竭患者的预测标志物:一项回顾性研究。
BMC Gastroenterol. 2024 Jun 4;24(1):191. doi: 10.1186/s12876-024-03276-x.
3
Development and validation of a predictive model for acute-on-chronic liver failure after transjugular intrahepatic portosystemic shunt.
经颈静脉肝内门体分流术后急性慢性肝衰竭预测模型的开发与验证
World J Gastrointest Surg. 2024 May 27;16(5):1301-1310. doi: 10.4240/wjgs.v16.i5.1301.
4
The value of dynamic changes in FT3 level for predicting 90-day prognosis of HBV-ACLF patients.FT3 水平动态变化对预测 HBV-ACLF 患者 90 天预后的价值。
Eur J Med Res. 2024 May 15;29(1):288. doi: 10.1186/s40001-024-01770-2.
5
Development of novel prognostic models based on dynamic changes in risk factors for hepatitis B associated acute-on-chronic liver failure:a 10-year retrospective study.基于乙型肝炎相关慢加急性肝衰竭危险因素动态变化的新型预后模型的开发:一项10年回顾性研究
Heliyon. 2024 Apr 4;10(7):e29276. doi: 10.1016/j.heliyon.2024.e29276. eCollection 2024 Apr 15.
6
Evidence-based hyponatremia management in liver disease.基于证据的肝脏疾病低钠血症管理。
Clin Mol Hepatol. 2023 Oct;29(4):924-944. doi: 10.3350/cmh.2023.0090. Epub 2023 Jun 5.
7
Development of a Widely Applicable and Simple Prognostic Score for Patients with Acute-on-chronic Liver Failure.一种适用于广泛人群的急性慢性肝衰竭患者简易预后评分系统的开发。
J Clin Transl Hepatol. 2022 Oct 28;10(5):867-878. doi: 10.14218/JCTH.2021.00328. Epub 2022 Jan 18.
8
Norepinephrine innervation of the supraoptic nucleus contributes to increased copeptin and dilutional hyponatremia in male rats.去甲肾上腺素对神经垂体的支配导致雄性大鼠copeptin 增加和稀释性低钠血症。
Am J Physiol Regul Integr Comp Physiol. 2022 Nov 1;323(5):R797-R809. doi: 10.1152/ajpregu.00086.2022. Epub 2022 Oct 3.
9
Clinical Implications, Evaluation, and Management of Hyponatremia in Cirrhosis.肝硬化患者低钠血症的临床意义、评估及管理
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):575-594. doi: 10.1016/j.jceh.2021.09.008. Epub 2021 Sep 16.
10
[Clinical Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Assessing Short-Term Mortality in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Treated with Artificial Liver Support System].基于胱抑素C的估算肾小球滤过率在评估人工肝支持系统治疗的乙型肝炎病毒相关性慢加急性肝衰竭患者短期死亡率中的临床价值
Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Sep;52(5):862-867. doi: 10.12182/20210660104.